708 studies found for:    Open Studies | "Bone Marrow Diseases"
Show Display Options
Rank Status Study
21 Recruiting Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
Conditions: Metabolic Disorders;   Hematologic, Immune, or Bone Marrow Disorders;   Hemoglobinopathies;   Non-malignant Disorders
Interventions: Drug: Transplant conditioning regimen of alemtuzumab, fludarabine, and melphalan;   Drug: Transplant conditioning regimen of hydroxyurea, campath, fludarabine, thiotepa, & melphalan
22 Unknown  Arthroplasty Versus Fusion in Anterior Cervical Surgery: Prospective Study of the Impact on the Adjacent Level
Conditions: Clinical Radiculopathy;   Myelopathy Due to a Cervical Disk Disease
Interventions: Device: cervical disc prosthesis with a mobile insert named Mobi-C;   Procedure: arthrodesis - cervical disk surgery
23 Unknown  Anesthesia Induction in Patients Undergoing Surgery for Cervical Myelopathy
Condition: Spinal Cord Diseases
Intervention: Drug: anaesthetics: sevofluorane
24 Recruiting A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders
Conditions: Thrombocytosis;   Myeloproliferative Neoplasms
Intervention: Drug: Anagrelide CR
25 Recruiting Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Conditions: Cancer;   Hematologic Malignancies;   Multiple Myeloma;   Oncology;   Bone Metastases;   Multiple Myeloma Bone Lesions
Interventions: Drug: Denosumab;   Drug: Zoledronic acid
26 Unknown  Bortezomib and Low Dose Cytarabine in the Treatment of High-Risk Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Intervention: Drug: Bortezomib
27 Available Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant
Conditions: Acute Lymphoblastic Leukemia;   Acute Myeloid Leukemia;   Chronic Myeloid Leukemia;   Myelodysplastic Syndrome;   Lymphomas;   Bone Marrow Failure;   Hemoglobinopathy;   Immune Deficiency;   Osteopetrosis;   Cytopenias;   White Blood Cell Abnormalities;   Red Blood Cell Abnormalities
Intervention: Biological: CD34+ enriched, T Cell Depleted donor stem cell product
28 Recruiting Lenalidomide and Eltrombopag in Low and Intermediate Risk MDS
Conditions: Myelodysplastic Syndrome;   MDS;   Anemia
Interventions: Drug: Lenalidomide;   Drug: Eltrombopag
29 Recruiting Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia
Conditions: Polycythemia Vera;   Essential Thrombocythemia
Intervention: Drug: Momelotinib
30 Recruiting Ruxolitinib Efficacy and Safety in Patients With HU Resistant or Intolerant Polycythemia Vera vs Best Available Therapy.
Condition: Polycythemia Vera
Interventions: Drug: Best Available Therapy;   Drug: ruxolitinib
31 Not yet recruiting AOP2014 in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study.
Condition: Polycythemia Vera
Intervention: Drug: Pegylated-Proline-interferon alpha-2b
32 Recruiting Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF
Conditions: Primary Myelofibrosis;   Post-Polycythemic Vera Myelofibrosis;   Post-Essential Thrombocythemia Myelofibrosis
Intervention: Drug: NS-018
33 Recruiting A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Condition: Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive
Interventions: Drug: Bosutinib;   Drug: Imatinib
34 Unknown  Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Interventions: Other: Human umbilical cord-derived MSCs;   Other: cyclosporine A (CsA)
35 Unknown  Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Severe Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Other: Human umbilical cord-derived MSCs and cyclosporin A;   Other: cyclosporin A
36 Recruiting Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis With Thrombocytopenia
Conditions: Primary Myelofibrosis;   Post-polycythemia Vera Myelofibrosis;   Post-essential Thrombocythemia Myelofibrosis
Interventions: Drug: Pacritinib;   Drug: Best Available Therapy
37 Recruiting Raltegravir for HAM/TSP
Conditions: HAM/TSP;   HTLV-1
Intervention: Drug: Raltegravir
38 Unknown  Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic Castration Resistant Prostate Cancer
Conditions: Metastatic Prostate Cancer;   Bone Metastasis
Intervention: Drug: Zoledronic acid
39 Recruiting Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis
Condition: Prostate Cancer
Intervention: Drug: Concurrent use of Radium Ra 223 dichloride and Abiraterone Acetate plus Prednisone
40 Recruiting Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate Cancer
Conditions: Bone Metastases;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Soft Tissue Metastases;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Other: laboratory biomarker analysis;   Other: cytology specimen collection procedure

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years